Drugmaker Amneal agrees to $270 million U.S. opioid settlement By Reuters
Written by Nate Raymond(Reuters) - Amnial Pharmaceuticals (Nasdaq) said on Friday it had reached an agreement worth more than $270 million to settle allegations that it helped fuel the deadly opioid epidemic in the United States, becoming…
